Hello Everyone,
We are reviewing our current practice and orderset for the treatment of acute hyperkalemia and I am interested in what other hospitals are doing.
• Has your site/health system removed kayexalate from formulary (Y/N)?
• Has your site/health system replaced kayexalate with Lokelma or added Lokelma
as an alternative?
o If so, what is the dosing regimen used?
• What systems are in place to ensure the safety of insulin administration?
If anyone would like to share their protocol/order set, it would be greatly appreciated!
Thank you for your insight!
Amy Dutko, PharmD